Ryuki Chatani, Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Michihisa Umetsu, Yuji Nishimoto, Takuma Takada, Yoshito Ogihara, Tatsuya Nishikawa, Nobutaka Ikeda, et al. Edoxaban for 12 Versus 3 Months in Cancer-associated Isolated Distal Deep Vein Thrombosis According to Different Doses: Insights from the ONCO DVT study. European heart journal. Cardiovascular pharmacotherapy. 2024
Yuki Ueno, Satoshi Ikeda, Tetsufumi Motokawa, Tomohiro Honda, Masaya Kurobe, Ryohei Akashi, Tsuyoshi Yonekura, Tsuyoshi Yoshimuta, Masamichi Eguchi, Hiroaki Kawano, et al. The Authors' Reply to "Efficacy and feasibility of edoxaban therapy without prior parenteral anticoagulants in patients with venous thromboembolism". Internal medicine (Tokyo, Japan). 2024
黒部 昌也, 山中 洋介, 宇田 晃仁, 森 力也, 明山 武嗣, 森下 亜由美, 石川 裕太, 池田 聡司, 前村 浩二. Practical Concerns over Implementing the Nagasaki Clinical Pathway for Secondary Prevention of Acute Myocardial Infarction: A Mixed Methods Study(タイトル和訳中). 日本循環器学会学術集会抄録集. 2024. 88回. OJ25-5
Clinical features of venous thrombosis in patients with COVID-19 in Japan -A case series study-
(The 41st Annual Meeting for Japanese Society of Phlebology 2021)
Cancer and venous thromboembolism - How useful is DOAC?-
(2021)
Cancer and thrombosis
(2020)
Cancer and venous thromboembolism - A new evidence of DOAC-
(2020)
日本臨床生理学会
, 日本心臓病学会
, 日本内科学会
, 日本循環器学会
, European Society of Cardiology
, 日本血管生物医学会
, 国際心血管薬物療法学会
, JAPANESE HEART RHYTHM SOCIETY
, 日本肺高血圧・肺循環学会
, 日本老年病学会
, Japanese College of Angiology
, 日本高血圧学会